Report cover image

Global Pressure Injectable PICC Kit Market Growth 2025-2031

Published Jun 04, 2025
Length 108 Pages
SKU # LPI20065466

Description

The global Pressure Injectable PICC Kit market size is predicted to grow from US$ 392 million in 2025 to US$ 477 million in 2031; it is expected to grow at a CAGR of 3.3% from 2025 to 2031.

A peripherally inserted central catheter is a peripherally inserted central venous catheter manufactured using medical grade, flexible polyurethane. It is suitable for male and female to use for long-duration. It is used for intravenous therapy, pressure injection, infusion, blood sampling, of contrast media and allows for the central venous pressure monitoring. The kit assists the clinician in maintaining maximal sterile barrier precautions. Wherever there are device-related infections or thrombosis in the intended injection vessel or catheter route, the Pressure Injectable PICC is contraindicated. To ensure there are no contraindications, a clinical assessment of the patient must be performed.

Chronic diseases such as cancer, cardiovascular diseases, and infectious diseases often require long-term intravenous therapy and frequent administration of medications. Pressure Injectable PICC (Peripherally Inserted Central Catheter) kits are commonly used for such purposes, providing a reliable and convenient pathway for medication administration and blood sampling. The growing prevalence of chronic diseases worldwide is driving the demand for Pressure Injectable PICC kits. Pressure Injectable PICC kits offer several advantages over traditional intravenous access devices, such as peripheral IV catheters and central venous catheters. These include longer dwell time, reduced risk of complications, improved patient comfort, and better cost-effectiveness. As healthcare providers recognize the benefits of Pressure Injectable PICC kits, there is an increasing adoption of these devices, contributing to market growth. The global population of older adults is increasing, leading to a higher incidence of chronic diseases and age-related conditions that require long-term intravenous therapy. Pressure Injectable PICC kits are commonly used in geriatric care settings due to their ease of use and long-term access capabilities. The growing elderly population is a significant driver for the market, as it fuels the demand for Pressure Injectable PICC kits. There is a growing trend towards home healthcare, driven by factors such as cost-effectiveness, convenience, and the desire for patient-centered care. Pressure Injectable PICC kits are well-suited for home healthcare settings, allowing patients to receive intravenous therapy or medication administration in the comfort of their own homes. The increasing focus on home healthcare is contributing to the demand for Pressure Injectable PICC kits. Manufacturers are continually developing and improving the design of Pressure Injectable PICC kits to enhance their performance and patient safety. This includes features such as antimicrobial coatings, improved catheter materials, and integrated pressure injectable ports. Technological advancements in catheter design are driving the market as healthcare providers seek more reliable and advanced devices for intravenous access. Increasing awareness regarding the benefits of Pressure Injectable PICC kits and training programs for healthcare professionals in their use and maintenance are driving market growth. Recognizing the importance of proper catheter selection and insertion techniques, healthcare facilities are investing in training programs to ensure safe and effective use of Pressure Injectable PICC kits. Reimbursement policies and coverage for Pressure Injectable PICC kits vary across different regions. However, there is an increasing trend towards favorable reimbursement policies for intravenous therapy and related devices. This encourages healthcare providers and facilities to adopt Pressure Injectable PICC kits, further driving market growth.

LP Information, Inc. (LPI) ' newest research report, the “Pressure Injectable PICC Kit Industry Forecast” looks at past sales and reviews total world Pressure Injectable PICC Kit sales in 2024, providing a comprehensive analysis by region and market sector of projected Pressure Injectable PICC Kit sales for 2025 through 2031. With Pressure Injectable PICC Kit sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pressure Injectable PICC Kit industry.

This Insight Report provides a comprehensive analysis of the global Pressure Injectable PICC Kit landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pressure Injectable PICC Kit portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pressure Injectable PICC Kit market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pressure Injectable PICC Kit and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pressure Injectable PICC Kit.

This report presents a comprehensive overview, market shares, and growth opportunities of Pressure Injectable PICC Kit market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

Power Injected PICC

Conventional PICC

Segmentation by Application:

Hospitals

Nursing Facilities

Home Care

Others

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.

AngioDynamics, Inc.

C. R. Bard Inc.

Teleflex Incorporated

B. Braun Melsungen AG

Medtronic plc

Vygon S.A

Cook Medical, Inc.

Boston Scientific Corporation

Argon Medical Devices, Inc.

Medical Component, Inc.

Theragenics Corporation

Key Questions Addressed in this Report

What is the 10-year outlook for the global Pressure Injectable PICC Kit market?

What factors are driving Pressure Injectable PICC Kit market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Pressure Injectable PICC Kit market opportunities vary by end market size?

How does Pressure Injectable PICC Kit break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.

Table of Contents

108 Pages
*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
2 Executive Summary
3 Global by Company
4 World Historic Review for Pressure Injectable PICC Kit by Geographic Region
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Manufacturing Cost Structure Analysis
11 Marketing, Distributors and Customer
12 World Forecast Review for Pressure Injectable PICC Kit by Geographic Region
13 Key Players Analysis
14 Research Findings and Conclusion
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.